TFF1 and gastric cancer: Indeed, more than 50% of gastric cancers show a reduced TFF1 expression due to some point mutations (Park et al., 2000), promoter polymorphic variants (Moghanibashi et al., 2012), but mostly to loss of heterozygosity (LOH) and hypermethylation of its promoter (Carvalho et al., 2002).